The Efficacy and Safety of Nabilone (A Synthetic Cannabinoid) in the Treatment of Anxiety
- 9 August 1981
- journal article
- clinical trial
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 21 (S1) , 377S-382S
- https://doi.org/10.1002/j.1552-4604.1981.tb02617.x
Abstract
The anxiolytic properties of nabilone, a synthetic cannabinoid resembling the natural cannabinoids, were studied in 25 outpatients suffering from anxiety. The drug was compared with a placebo in a double‐blind manner over a 28‐day treatment period. Patients were seen weekly by the physician and were rated by the Hamilton Rating Scale for Anxiety and the Patient's Global Evaluation as well as by patient‐rated evaluations. The results of the study showed a dramatic improvement in anxiety in the nabilone group when compared with placebo (P < 0.001). Side effects reported were dry mouth, dry eyes, and drowsiness. Patients did not report any of the subjective “altered state” experience of marihuana.Keywords
This publication has 6 references indexed in Scilit:
- Single‐Dose Study of Nabilone in Anxious VolunteersThe Journal of Clinical Pharmacology, 1981
- A model for evaluation of antianxiety drugs with the use of experimentally induced stress: Comparison of nabilone and diazepamClinical Pharmacology & Therapeutics, 1978
- Suppression of the cardiac conditioned response by ?-9-tetrahydrocannabinol: A comparison with other drugsPsychopharmacology, 1976
- Clinical pharmacology of nabilone, a cannabinol derivativeClinical Pharmacology & Therapeutics, 1975
- Does marijuana enhance experimentally induced anxiety?Psychopharmacology, 1974
- Changes in Anxiety Feelings Following Marihuana SmokingBritish Journal of Addiction to Alcohol & Other Drugs, 1971